CSIMarket
 


Luna Innovations Inc  (LUNA)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

LUNA's Income from Cont. Operations Growth by Quarter and Year

Luna Innovations Inc's Income from Cont. Operations results by quarter and year




LUNA Income from Cont. Operations (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 1.17 -0.34 3.10
III Quarter September 0.46 -2.94 -0.23 1.37
II Quarter June -0.56 -1.34 -0.32 0.32
I Quarter March -1.84 -0.20 -0.06 2.15
FY   -1.94 -3.31 -0.95 6.94



LUNA Income from Cont. Operations third quarter 2023 Y/Y Growth Comment
Luna Innovations Inc in the third quarter 2023 achieved Income from Cont. Operations of $ 0.46 millions compare to loss from continued operations recorded in same quarter a year ago.

According to the results reported in the third quarter 2023, Luna Innovations Inc achieved the best Income from Cont. Operations growth in Medical Laboratories industry. While Luna Innovations Inc' s Income from Cont. Operations no change of % ranks overall at the positon no. in the third quarter 2023.




LUNA Income from Cont. Operations ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - 152.03 %
III Quarter September - - - 63.1 %
II Quarter June - - - -71.68 %
I Quarter March - - - -81.12 %
FY   - - - -52.43 %

Financial Statements
Luna Innovations Inc's third quarter 2023 Income from Cont. Operations $ 0.46 millions LUNA's Income Statement
Luna Innovations Inc's third quarter 2022 Income from Cont. Operations $ -2.94 millions Quarterly LUNA's Income Statement
New: More LUNA's historic Income from Cont. Operations Growth >>


LUNA Income from Cont. Operations (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - 126.28 %
III Quarter September - - - 328.13 %
II Quarter June - - - -85.12 %
I Quarter March - - - 74.8 %
FY (Year on Year)   - - - -52.43 %




Income from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Luna Innovations Inc's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LUNA's III. Quarter Q/Q Income from Cont. Operations Comment
This reversal of fortune III. Quarter 2023where Luna Innovations Inc published Income from Cont. Operations of $ 0.46 millions should be inception of positive performance.Luna Innovations Inc announced in the III. Quarter 2023 Income from Cont. Operations of $ 0.46 millions compare to loss from continued operations recorded in previos quarter.

Within Medical Laboratories industry Luna Innovations Inc achieved highest sequential Income from Cont. Operations growth. While Luna Innovations Inc's Income from Cont. Operations growth quarter on quarter, overall rank is .


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


LUNA's III. Quarter Q/Q Income from Cont. Operations Comment
Improvement III. Quarter 2023where Luna Innovations Inc delivered Income from Cont. Operations of $ 0.46 millions could be considered as a starting point of improved business climet.Luna Innovations Inc announced in the III. Quarter 2023 Income from Cont. Operations of $ 0.46 millions compare to loss from continued operations recorded in previos quarter.

Within Medical Laboratories industry Luna Innovations Inc achieved highest sequential Income from Cont. Operations growth. While Luna Innovations Inc's Income from Cont. Operations growth quarter on quarter, overall rank is .


Luna Innovations Inc's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Income from Cont. Operations 12 Months Ending $ -0.77 $ -4.17 $ -4.96 $ -3.31 $ -4.83
Y / Y Income from Cont. Operations Growth (TTM) - - - - -
Year on Year Income from Cont. Operations Growth Overall Ranking # # # # #
Seqeuential Income from Cont. Operations Change (TTM) - - - - -
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # # # # #




Cumulative Income from Cont. Operations growth Comment


Luna Innovations Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income from Cont. Operations growth Comment


Luna Innovations Inc achieved highest trailing twelve month year on year Income from Cont. Operations growth. While overall Income from Cont. Operations growth ranking, remained unchanged compare to the previous quarter at no. .

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income from Cont. Operations Growth
Medical Laboratories Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
LUNA's Income from Cont. Operations Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for LUNA's Competitors
Income from Cont. Operations Growth for Luna Innovations Inc's Suppliers
Income from Cont. Operations Growth for LUNA's Customers

You may also want to know
LUNA's Annual Growth Rates LUNA's Profitability Ratios LUNA's Asset Turnover Ratio LUNA's Dividend Growth
LUNA's Roe LUNA's Valuation Ratios LUNA's Financial Strength Ratios LUNA's Dividend Payout Ratio
LUNA's Roa LUNA's Inventory Turnover Ratio LUNA's Growth Rates LUNA's Dividend Comparisons



Companies with similar Income from Cont. Operations no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2023
Shockwave Medical Inc -0.05%$ -0.049 millions
Xeris Biopharma Holdings Inc -0.29%$ -0.295 millions
Tenet Healthcare Corp-0.75%$ -0.746 millions
U S Physical Therapy Inc-4.67%$ -4.672 millions
Universal Health Services Inc -4.98%$ -4.979 millions
National Research Corporation-5.09%$ -5.086 millions
Hca Healthcare Inc -5.13%$ -5.134 millions
Viatris Inc -6.41%$ -6.407 millions
Pacific Health Care Organization Inc -6.71%$ -6.710 millions
Mettler toledo International Inc -8.60%$ -8.598 millions
Corcept Therapeutics Inc-9.78%$ -9.777 millions
Charles River Laboratories International inc -9.83%$ -9.826 millions
Third Harmonic Bio Inc -10.51%$ -10.506 millions
The Pennant Group Inc -10.65%$ -10.653 millions
Henry Schein Inc-11.73%$ -11.728 millions
Quest Diagnostics Inc-14.13%$ -14.130 millions
Carlisle Companies Incorporated-15.01%$ -15.008 millions
Stryker Corp-15.20%$ -15.196 millions
Zimmer Biomet Holdings Inc -16.12%$ -16.117 millions
Amgen Inc -19.27%$ -19.272 millions
Entera Bio Ltd -22.43%$ -22.432 millions
Regeneron Pharmaceuticals Inc -23.40%$ -23.402 millions
Pediatrix Medical Group Inc -25.75%$ -25.746 millions
Zynex inc -26.25%$ -26.247 millions
Evofem Biosciences Inc -26.26%$ -26.256 millions
Tenax Therapeutics Inc -32.39%$ -32.386 millions
Avantor Inc -35.09%$ -35.090 millions
Ufp Technologies Inc -40.15%$ -40.154 millions
Bio techne Corp-43.17%$ -43.173 millions
Royalty Pharma Plc-44.61%$ -44.615 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com